Your browser doesn't support javascript.
loading
Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib.
Miao, Emily; Eichholz, Jordan E; Lebow, Emily S; Flynn, Jessica; Zhang, Zhigang; Walch, Henry; Hubbeling, Harper; Beal, Kathryn; Moss, Nelson S; Yu, Kenny K; Meng, Alicia; Kelly, Daniel W; Gomez, Daniel R; Li, Bob T; Rimner, Andreas; Schultz, Nikolaus; Drilon, Alexander; Imber, Brandon S; Pike, Luke R G.
Affiliation
  • Miao E; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States; Albert Einstein College of Medicine, Bronx, NY, United States.
  • Eichholz JE; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States; Biomarker Development Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Lebow ES; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Flynn J; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Zhang Z; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Walch H; Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Hubbeling H; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Beal K; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Moss NS; Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Yu KK; Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Meng A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Kelly DW; Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Gomez DR; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States; Biomarker Development Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Li BT; Memorial Sloan Kettering Cancer Center, New York, New York, United States; Biomarker Development Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Rimner A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States; Biomarker Development Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Schultz N; Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Drilon A; Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Imber BS; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
  • Pike LRG; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States; Biomarker Development Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States. Electronic address: Pikel@mskcc.org.
Lung Cancer ; 178: 57-65, 2023 04.
Article in En | MEDLINE | ID: mdl-36780766

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Country of publication: